- Home
- CRBU vs MACI Comparison
CRBU vs MACI Comparison
Compare CRBU & MACI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRBU
- MACI
- Stock Information
- Founded
- CRBU 2011
- MACI 2024
- Country
- CRBU United States
- MACI United States
- Employees
- CRBU N/A
- MACI N/A
- Industry
- CRBU Medicinal Chemicals and Botanical Products
- MACI
- Sector
- CRBU Health Care
- MACI
- Exchange
- CRBU Nasdaq
- MACI NYSE
- Market Cap
- CRBU 236.3M
- MACI 215.8M
- IPO Year
- CRBU 2021
- MACI 2024
- Fundamental
- Price
- CRBU $2.68
- MACI $10.05
- Analyst Decision
- CRBU Strong Buy
- MACI
- Analyst Count
- CRBU 4
- MACI 0
- Target Price
- CRBU $14.00
- MACI N/A
- AVG Volume (30 Days)
- CRBU 1.5M
- MACI 22.1K
- Earning Date
- CRBU 11-06-2024
- MACI 01-01-0001
- Dividend Yield
- CRBU N/A
- MACI N/A
- EPS Growth
- CRBU N/A
- MACI N/A
- EPS
- CRBU N/A
- MACI N/A
- Revenue
- CRBU $11,475,000.00
- MACI N/A
- Revenue This Year
- CRBU N/A
- MACI N/A
- Revenue Next Year
- CRBU $3.24
- MACI N/A
- P/E Ratio
- CRBU N/A
- MACI N/A
- Revenue Growth
- CRBU N/A
- MACI N/A
- 52 Week Low
- CRBU $1.50
- MACI $9.95
- 52 Week High
- CRBU $8.33
- MACI $10.05
- Technical
- Relative Strength Index (RSI)
- CRBU 72.23
- MACI N/A
- Support Level
- CRBU $2.37
- MACI N/A
- Resistance Level
- CRBU $3.00
- MACI N/A
- Average True Range (ATR)
- CRBU 0.23
- MACI 0.00
- MACD
- CRBU 0.09
- MACI 0.00
- Stochastic Oscillator
- CRBU 73.98
- MACI 0.00
About CRBU Caribou Biosciences Inc.
Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) biopharmaceutical company dedicated to transforming the lives of patients with devastating diseases by applying its novel CRISPR platform, CRISPR hybrid RNA-DNA (chRDNA), toward the development of next-generation, genome-edited cell therapies. The company operates and manage business as one reportable operating segment, which is the business of developing a pipeline of allogeneic CAR-T and CAR-NK cell therapies.
About MACI MELAR ACQUISITION CORP. I
Melar Acquisition Corp I is a blank check company.